This is a Haleon news story, published by Yahoo Finance, that relates primarily to Pfizer news.
For more Haleon news, you can click here:
more Haleon newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
British consumer healthcare company Haleon. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest top shareholder news, sale news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
PfizerReuters
•82% Informative
Pfizer intends to sell 540 million shares in British consumer healthcare company Haleon .
The top shareholder's interest in the Sensodyne maker to 16.2% .
Haleon separately said it had agreed to make an off-market purchase of about 230 million pounds ( $308.18 million ) Pfizer had sold about $3.5 billion worth stake in Haleon in March .
VR Score
92
Informative language
97
Neutral language
86
Article tone
formal
Language
English
Language complexity
48
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links